Q98447822

Summary

Q98447822 is an interpellation^[1].

Key Facts

• Q98447822 authored Leif Carlson^[2].
• Q98447822's instance of is recorded as interpellation^[3].
• Q98447822's part of the series is recorded as interpellations of the 2001/02 legislative session of the Riksdag^[4].
• Q98447822's language of work or name is recorded as Swedish^[5].
• Q98447822 was published on +2001-10-01T00:00:00Z^[6].
• Q98447822's significant event is recorded as debate^[7].
• Q98447822's main subject is medication^[8].
• Q98447822's work available at URL is recorded as http://data.riksdagen.se/dokument/GP1020^[9].
• Q98447822's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/GP1020^[10].
• Q98447822's applies to jurisdiction is recorded as Sweden^[11].
• Q98447822's legal citation of this text is recorded as ip. 2001/02:20^[12].
• Q98447822's title is recorded as läkemedelskostnader^[13].
• Q98447822's addressee is recorded as Bosse Ringholm^[14].
• Q98447822's maintained by WikiProject is recorded as Project Riksdagen's documents^[15].
• Q98447822's copyright status is recorded as public domain^[16].

Body

Definition and Type

Q98447822's instance of is recorded as interpellation^[3].